51 research outputs found
Aesthetic Coatings for Concrete Bridge Components
This thesis evaluated the durability and aesthetic performance of coating systems for utilization in concrete bridge applications. The principle objectives of this thesis were: 1) Identify aesthetic coating systems appropriate for concrete bridge applications; 2) Evaluate the performance of the selected systems through a laboratory testing regimen; 3) Develop guidelines for coating selection, surface preparation, and application.
A series of site visits to various bridges throughout the State of Wisconsin provided insight into the performance of common coating systems and allowed problematic structural details to be identified. To aid in the selection of appropriate coating systems, questionnaires were distributed to coating manufacturers, bridge contractors, and various DOT offices to identify high performing coating systems and best practices for surface preparation and application. These efforts supplemented a literature review investigating recent publications related to formulation, selection, surface preparation, application, and performance evaluation of coating materials
Structurally Controlled Bio-hybrid Materials Based on Unidirectional Association of Anisotropic Microparticles with Human Endothelial Cells
No Abstract.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/64554/1/4920_ftp.pd
Freely Suspended Cellular “Backpacks” Lead to Cell Aggregate Self-Assembly
Cellular “backpacks” are a new type of anisotropic, nanoscale thickness microparticle that may be attached to the surface of living cells creating a “bio-hybrid” material. Previous work has shown that these backpacks do not impair cell viability or native functions such as migration in a B and T cell line, respectively. In the current work, we show that backpacks, when added to a cell suspension, assemble cells into aggregates of reproducible size. We investigate the efficiency of backpack−cell binding using flow cytometry and laser diffraction, examine the influence of backpack diameter on aggregate size, and show that even when cell−backpack complexes are forced through small pores, backpacks are not removed from the surfaces of cells.National Science Foundation (U.S.). Materials Research Science and Engineering Centers (Program) (Award DMR-08-19762)National Science Foundation (U.S.) (Graduate Research Fellowship)United States. Dept. of DefenseUnited States. Air Force Office of Scientific ResearchHoward Hughes Medical Institute (Investigator)United States. Dept. of Defense (National Defense Science and Engineering Graduate Fellowship 32 CFR 168a
Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study
BACKGROUND: Placental growth factor (PlGF), pregnancy-associated plasma protein-A (PAPP-A), soluble receptor for advanced glycation end products (sRAGE), extracellular newly identified receptor for RAGE binding protein (EN-RAGE) and high mobility group box 1 (HMGB-1) are novel biomarkers in chronic kidney disease (CKD). However, their clinical significance in acute kidney injury (AKI) is unknown. The aim of this cross-sectional study was to determine whether selected biomarkers are changed in AKI patients. METHODS: Serum PlGF, PAPP-A, sRAGE, EN-RAGE and HMGB-1 levels were assessed in 40 patients with AKI, 42 CKD 5 patients, 31 haemodialysis patients (HD) and 39 age-matched healthy controls. RESULTS: PAPP-A was elevated in AKI (20.6 ± 16.9 mIU/L) compared with controls (9.1 ± 2.3 mIU/L, p < 0.001). PlGF was not increased in AKI (11.7 ± 7.4 pg/mL) versus controls (8.5 ± 2.4 pg/mL, n.s.), as well as sRAGE was not elevated in AKI (2400 ± 1400 pg/mL) compared with controls (1760 ± 730 pg/mL, n.s), but was lower compared with CKD 5 (3200 ± 1500 pg/mL, p < 0.05); EN-RAGE was elevated in AKI 480 ± 450 ng/mL in comparison with controls (60 ± 62 ng/mL), CKD 5 (190 ± 120 ng/mL), and HD (120 ± 100 ng/mL), all p < 0.001. Similarly, HMGB-1 was increased in AKI (5.8 ± 7.5 ng/mL) versus controls (1.7 ± 1.4 ng/mL), CKD 5 (3.2 ± 3.1 ng/mL) and HD (2.5 ±2.1 ng/mL), all p < 0.001. In AKI group, in multivariate regression analysis: PAPP–A levels were associated with transferrin (p <0.001), negatively with albumin (p < 0.01) and prealbumin (p < 0.05); PlGF levels were associated with C - reactive protein (p < 0.001). EN-RAGE levels were associated with ferritin (p < 0.01) and orosomucoid (p = 0.02), and HMGB-1 levels with leukocyte count (p < 0.01) and negatively with proteinuria (p = 0.02). CONCLUSIONS: In AKI patients, PAPP-A, EN-RAGE and HMGB1 are elevated, but sRAGE and PlGF are not increased. Whereas PAPP-A correlates with markers of nutrition; PlGF, EN-RAGE and HMGB-1 are related to inflammatory parameters
Recommended from our members
Development of a Small-Scale Natural Gas Liquefier. Final Report
This final report describes the progress during the contract period March 1, 1998 through April 30, 2003, on the design, development, and testing of a novel mixed-refrigerant-based 1000 gal/day natural gas liquefier, together with the associated gas cleanup equipment. Based on the work, it is concluded that a cost-effective 1000 gal/day liquefaction system is technically and economically feasible. A unit based on the same developed technology, with 5000 gal/day capacity, would have much improved economics
- …